Cardinal Health Change in Accounts Payable 2010-2023 | CAH

Cardinal Health annual/quarterly change in accounts payable history and growth rate from 2010 to 2023. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
  • Cardinal Health change in accounts payable for the quarter ending December 31, 2023 was $4.446B, a 50.51% increase year-over-year.
  • Cardinal Health change in accounts payable for the twelve months ending December 31, 2023 was $11.364B, a 30.07% increase year-over-year.
  • Cardinal Health annual change in accounts payable for 2023 was $2.718B, a 20.71% decline from 2022.
  • Cardinal Health annual change in accounts payable for 2022 was $3.428B, a 47.44% increase from 2021.
  • Cardinal Health annual change in accounts payable for 2021 was $2.325B, a 1535.19% decline from 2020.
Cardinal Health Annual Change in Accounts Payable
(Millions of US $)
2023 $2,718
2022 $3,428
2021 $2,325
2020 $-162
2019 $1,864
2018 $2,574
2017 $564
2016 $2,815
2015 $1,948
2014 $-196
2013 $426
2012 $319
2011 $1,356
2010 $451
2009 $768
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.731B $205.012B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.697B 20.12
Becton Dickinson (BDX) United States $67.917B 19.22
West Pharmaceutical Services (WST) United States $25.821B 46.28
Align Technology (ALGN) United States $20.934B 40.42
Cooper (COO) United States $19.073B 28.86
Labcorp (LH) United States $17.804B 15.33
Henry Schein (HSIC) United States $9.318B 16.58
DENTSPLY SIRONA (XRAY) United States $5.839B 15.12
Merit Medical Systems (MMSI) United States $4.788B 26.24
Patterson (PDCO) United States $2.279B 10.92
CONMED (CNMD) United States $2.232B 20.24
STAAR Surgical (STAA) United States $2.145B 82.36
Atrion (ATRI) United States $0.837B 44.72
Lifevantage (LFVN) United States $0.089B 11.48
Pro-Dex (PDEX) United States $0.066B 33.33
Biolase (BIOL) United States $0.005B 0.00